Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
October 02, 2024 06:30 ET
|
GENENTA SCIENCE SPA
Genenta Secures Approval for Innovative Trial for
Metastatic Renal Cell Cancer
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
May 29, 2024 08:00 ET
|
Genetic Technologies Ltd
Genetic Technologies Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
May 06, 2024 06:25 ET
|
GENENTA SCIENCE SPA
MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power...
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
April 16, 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
GTG Global Collaborations and Innovation Update
March 26, 2024 08:00 ET
|
Genetic Technologies Ltd
GTG Global Collaborations and Innovation Update
Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
March 26, 2024 05:00 ET
|
Laverock Therapeutics
STEVENAGE, United Kingdom, March 26, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
March 25, 2024 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, March 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GENE”), a global leader in guideline-driven genomics-based testing in health, wellness...
GTG to launch U.S. Customer Digital Media Sales Campaign
February 28, 2024 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), is pleased to announce the launch of a wide-reaching customer – targeted...
Launching our most comprehensive test and expanding into new global markets
January 31, 2024 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE), is at the forefront in personalised predictive genomics, reshaping the healthcare landscape with...
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
January 05, 2024 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”) a global leader in genomics-based tests in health, wellness, and serious disease,...